Vickers Vantage Corp I
Vickers Venture SPAC VCKA to merge with US biopharmaceutical firm Scilex
Vickers Venture Partners' Nasdaq-listed special purpose acquisition company (SPAC) Vickers Vantage Corp I is merging with Scilex Holding Company (Scilex), a majority-owned subsidiary of US pharma firm Sorrento Therapeutics, Inc and a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute…
